Vaccine efficacy drops from 72% to 40% after six months
Infection mutation under 12
Last week, the Higher Institute of Health wrote, there is an increase in incidence in all age groups and especially in the under-12-year-old population. Specifically in this age group, “from November 8 to 21, 2021, 31,365 new cases were reported, of which 153 are in hospital and 3 are in intensive care.” In the 6- to 11-year-old group, “beginning with the second week of October, there is a greater increase in incidence than in the rest of the school-age population, with an increase in the last two weeks”.
“There has also been an increase in the rate of hospitalization in the under three age group (just over 2 per 100,000 population) in the past few weeks, while it has been stable in other age groups.” Finally, in the past week, the trend observed in the previous week was confirmed, with 27% of cases diagnosed in the school-age population. 51% of school-aged cases were diagnosed in the 6-11 age group, 32% in the 12-19 age group and only 11% and 6% were diagnosed between 3 and 5 years of age, respectively, and less than 3 years old.
Vaccines, protection drops to 40% at 6 months of age The document highlights that “six months after the end of the vaccination cycle, the efficacy in preventing any symptomatic or asymptomatic diagnosis of Covid decreases from 72% to 40% compared to those vaccinated,” but the efficacy of vaccination in preventing cases remains high. severe illness; For those vaccinated with a full course of less than six months, the rate is 91% compared to the unvaccinated, while it is 81% for those vaccinated with a full course of more than six months compared to those who were not vaccinated.
“Food expert. Unapologetic bacon maven. Beer enthusiast. Pop cultureaholic. General travel scholar. Total internet buff.”
